AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Arcutis Biotherapeutics, Inc. Director's Dealing 2021

Sep 8, 2021

31600_dirs_2021-09-07_ffe12acd-d12d-4a7d-a5ea-7b5008fc517a.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Arcutis Biotherapeutics, Inc. (ARQT)
CIK: 0001787306
Period of Report: 2021-09-02

Reporting Person: Leonard Keith R (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2500	Direct